WO2012088762A1 - Method for determining free polysaccharide content in meningococcal polysaccharide conjugate - Google Patents

Method for determining free polysaccharide content in meningococcal polysaccharide conjugate Download PDF

Info

Publication number
WO2012088762A1
WO2012088762A1 PCT/CN2011/002180 CN2011002180W WO2012088762A1 WO 2012088762 A1 WO2012088762 A1 WO 2012088762A1 CN 2011002180 W CN2011002180 W CN 2011002180W WO 2012088762 A1 WO2012088762 A1 WO 2012088762A1
Authority
WO
WIPO (PCT)
Prior art keywords
polysaccharide
sample
conjugate
meningococcal
group
Prior art date
Application number
PCT/CN2011/002180
Other languages
French (fr)
Chinese (zh)
Inventor
王婷婷
魏文进
何佳琦
Original Assignee
北京民海生物科技有限公司
深圳康泰生物制品股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京民海生物科技有限公司, 深圳康泰生物制品股份有限公司 filed Critical 北京民海生物科技有限公司
Publication of WO2012088762A1 publication Critical patent/WO2012088762A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/22Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Definitions

  • the invention belongs to the field of biotechnology, and relates to a method for determining a free polysaccharide, in particular to a method for determining the content of free polysaccharide in a polysaccharide combination of eight, C, W135 and Y meningococcus. Background technique
  • Meningococcal infection is the leading cause of bacterial meningitis and fulminant sepsis in children. According to statistics, the annual incidence of meningococcal meningitis in the world is about 500,000, especially in developing countries. Worldwide, most meningitis diseases are caused by meningococcal bacteria such as group A, group B, group C, group Y and group W135, and safe and effective vaccination is an ideal measure to prevent and control meningitis.
  • meningitis vaccines at home and abroad mainly include polysaccharide vaccines and polysaccharide conjugate vaccines, among which: the antigen of the polysaccharide vaccine is a hapten, which is a non-T cell-dependent antigen, and the immune response induced by it does not involve T lymphocytes. It is not possible to produce immune memory. Therefore, WHO has suggested that the meningococcal polysaccharide vaccine is generally not used for the inoculation of infants and young children under 2 years old.
  • the meningococcal polysaccharide conjugate vaccine is a combination of the extracted meningococcal capsular polysaccharide and protein carrier.
  • the antigen is a T cell-dependent antigen, and the induced immune response is involved in T lymphocytes, which can stimulate the body to produce high levels of antibodies, enhance the immune memory of infants and young children, and thereby improve the immune effect.
  • the content of free polysaccharide in the polysaccharide conjugate vaccine is one of the key indicators for the quality control of polysaccharide conjugate vaccine.
  • the free polysaccharide content exceeding the prescribed limit will have an adverse effect on the clinical effect of the vaccine. Therefore, the free polysaccharide content is an important indicator reflecting the quality of the combined vaccine.
  • hydrophobic chromatography and HPLC methods were used to determine the free polysaccharides in polysaccharide conjugates. However, due to the influence of similar molecular size on the impurities during the chromatographic process, the error of the determination results was large.
  • Chinese Zhu Wei et al. introduced the determination of group A meningococcal polysaccharide-tetanus toxoid by ethanol precipitation method in the establishment of a method for determination of free polysaccharide in group A meningococcal polysaccharide-tetanus toxoid.
  • the method of free polysaccharides but the method is cumbersome to operate. It takes several days for a sample to obtain the results. At the same time, there may be some error in the detection of samples with low free polysaccharide content.
  • 200610048876.9 discloses a method for determining a free polysaccharide of a group A and C meningococcal polysaccharide conjugate, which requires adding a cold phenol solution to the sample for shaking, but the cold phenol is more toxic, to the skin and mucous membranes. It is strongly corrosive. Long-term exposure can inhibit central nervous system or impair liver and kidney function. Inhalation of phenol can also cause headache, dizziness, fatigue, blurred vision, pulmonary edema and other symptoms.
  • the invention provides a method for overcoming the lack of free polysaccharide content in the prior method, which can accurately determine the content of free polysaccharide in the polysaccharide combination of A, C, W135 and Y meningococcal polysaccharides, and the operation method is simple and rapid.
  • the invention provides a method for determining a free polysaccharide of a meningococcal polysaccharide conjugate, comprising the following steps: sampling, centrifuging, calculating a polysaccharide concentration, calculating a free polysaccharide content, wherein during centrifugation, a meningococcal polysaccharide conjugate and a test are to be tested A sodium deoxycholate solution is added to the corresponding derivative of the meningococcal polysaccharide conjugate. :
  • the method for determining a free polysaccharide in a meningococcal polysaccharide conjugate comprises the following steps:
  • Group A meningococcal polysaccharide conjugates were used to determine the phosphorus content, and the phosphorus content was used to calculate the polysaccharide concentrations of sample 1, sample 2, sample 3, and sample 4; group C, group W135, and group Y meningococcal polysaccharide conjugates were used to determine the sialic acid content.
  • the polysaccharide concentrations of Sample 1, Sample 2, Sample 3, and Sample 4 were calculated from the sialic acid content, and the polysaccharide concentrations of Sample 1, Sample 2, Sample 3, and Sample 4 were respectively Cl, C2, C3, and C4.
  • the meningococcal polysaccharide conjugate is a group A, group C, group W135 or group Y meningococcal polysaccharide conjugate.
  • the method for determining the free polysaccharide content of the group A meningococcal polysaccharide conjugate provided by the invention comprises the following steps:
  • the group A polysaccharide concentration phosphorus content / 0.08 in the formula and the coefficient in the formula 0.08 reference from "Embrane Miao", Zhang Yanling.
  • the method for determining the free polysaccharide content of the group C meningococcal polysaccharide conjugate provided by the invention comprises the following steps:
  • the C group polysaccharide concentration sialic acid content / 0.8 in the formula and the coefficient in the formula are referenced from "Vaccine”, Zhang Yanling.
  • the method for determining the free polysaccharide content of the W135 group meningococcal polysaccharide conjugate provided by the invention comprises the following steps:
  • the W135 group polysaccharide concentration phosphorus content / 0.56 formula and the coefficient of the formula 0.56 are referenced from "vaccine", Zhang Yanling.
  • the method for determining the free polysaccharide content of the Y group meningococcal polysaccharide conjugate provided by the invention comprises the following steps:
  • the W135 group polysaccharide concentration phosphorus content / 0.56 formula and the coefficient in the formula 0.56 reference from "vaccine” (Zhang Yanling).
  • the concentration unit of the DOC is 1% (lg/100 ml);
  • the concentration unit of the hydrochloric acid is mol/L, abbreviated as M;
  • the phosphorus content in the polysaccharide conjugate is determined by the phosphorus assay in the third edition of Appendix VIIA of the 2010 edition of the Chinese Pharmacopoeia.
  • the sialic acid content in the polysaccharide conjugate is used in the 2010 edition of the Chinese Pharmacopoeia. Determination by resorcinol colorimetry.
  • the present invention provides a method for accurately and rapidly determining the content of free polysaccharides in a combination of group A, group C, group W135 and group Y meningococcus, thereby evaluating the quality of the product.
  • the invention utilizes the characteristics of DOC (sodium deoxycholate) which can precipitate proteins under acidic conditions. After the sample is treated by DOC and centrifuged at high speed, the conjugate in the conjugate vaccine is precipitated and the polysaccharide remains in the supernatant under the same conditions. In this way, the bound polysaccharide is separated from the free polysaccharide, and the content of the free polysaccharide can be calculated by separately measuring the polysaccharide content of the centrifugation supernatant and the stock solution.
  • DOC sodium deoxycholate
  • the recovery ratio P is between 80 and 120%, and higher than 90% means high accuracy.
  • Centrifugation Take another 1 ml of the group A meningococcal polysaccharide conjugate in a 1.5 ml centrifuge tube, and take 1 ml of the derivative solution corresponding to the group A meningococcal polysaccharide conjugate to be tested in another 1.5 ml centrifuge tube. Add ⁇ 1% DOC solution to each centrifuge tube, keep icolo for 30 minutes, then add 0.5 ⁇ H0.5 solution to 25 ⁇ 1, shake well, centrifuge at 5000rpm for 15-20 minutes, collect supernatant 1ml separately from each centrifuge tube. , wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4.
  • the phosphorus content in the sample was determined by the phosphorus method in the third edition of Appendix VIIA of the 2010 edition of the Chinese Pharmacopoeia.
  • Example 5 using the method provided in Example 1 of the present invention to determine three batches of meningococcal group A polysaccharide conjugate samples The test results are shown in Table 1.
  • the results in Table 1 show that: The method provided by the present invention can accurately determine the content of free polysaccharide in the polysaccharide combination of meningococcal group A.
  • Centrifugation Take another 1 ml of the group C meningococcal polysaccharide conjugate in a 1.5 ml centrifuge tube, and take 1 ml of the derivative solution corresponding to the group C meningococcal polysaccharide conjugate to be tested in another 1.5 ml centrifuge tube.
  • the content of sialic acid in the sample was determined by the sialic acid content determination method in the third edition of Appendix VI of the 2010 edition of the Chinese Pharmacopoeia.
  • Centrifugation Take another 1 ml of the W135 group meningococcal polysaccharide conjugate in a 1.5 ml centrifuge tube, and take 1 ml of the derivative solution corresponding to the W135 group meningococcal polysaccharide conjugate to be placed in another 1.5 ml centrifuge tube. Add ⁇ 1% DOC solution to each centrifuge tube, hold for 30 minutes in an ice bath, then add 0.5 ⁇ L of 0.5 ⁇ HCL solution, shake well, centrifuge at 5000 rpm for 15-20 minutes, and collect supernatant 1 ml separately from each centrifuge tube. , wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
  • meningococcal W135 group polysaccharide composition samples were determined by the method provided in Example 1 of the present invention, and the test results are shown in Table 3:
  • Centrifugation Take another 1 ml of the Y group meningococcal polysaccharide conjugate in a 1.5 ml centrifuge tube, and take 1 ml of the derivative solution corresponding to the Y group meningococcal polysaccharide conjugate to be placed in another 1.5 ml centrifuge tube. Add ⁇ 1% DOC solution to each centrifuge tube, keep ice for 30 minutes, then add 0.5 ⁇ H0.5 solution to 25 ⁇ 1, shake well, centrifuge at 5000rpm for 15-20 minutes, collect supernatant 1ml separately from each centrifuge tube. , wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
  • Example 1 of the present invention Using the method provided in Example 1 of the present invention, three batches of meningococcal Y group polysaccharide conjugate samples were determined, and the test results are shown in Table 4:
  • meningococcal W135 group polysaccharide composition samples were determined by the method provided in Example 1 of the present invention, and the test results are shown in Table 5:
  • centrifugation Another group of Y group meningococcal polysaccharide conjugate lml placed in a 1.5ml centrifuge tube, Take 1 ml of the derivative solution corresponding to the Y group meningococcal polysaccharide conjugate to be placed in another 1.5 ml centrifuge tube; add 100 ⁇ l 1% DOC solution to each centrifuge tube, keep ice for 30 minutes, then add 0.5 25 ⁇ l of M HCL solution, fully shaken, centrifuged at 6000 rpm for 15-20 minutes, and each supernatant was separately collected 1 ml of the supernatant, wherein the supernatant of the conjugate was sample 2, and the supernatant of the derivative was sample 4;
  • the invention utilizes the characteristics of sodium deoxycholate (DOC) to precipitate proteins under acidic conditions.
  • DOC sodium deoxycholate
  • the conjugate in the conjugate vaccine is precipitated and the polysaccharide remains in the supernatant under the same conditions.
  • the bound polysaccharide is separated from the free polysaccharide, and the content of the free polysaccharide can be calculated by separately measuring the polysaccharide content of the centrifugation supernatant and the stock solution.
  • the method can accurately and quickly determine the content of the polysaccharides in the polysaccharide combination of the sputum group, the C group, the W135 group and the Y group meningococcus, thereby evaluating the quality of the product.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Provided is a method for determining free polysaccharide content in meningococcal Groups A, C, W135, and Y polysaccharide conjugate, comprising the following steps: 1) sampling: respectively taking 1 ml of a solution of meningococcal polysaccharide conjugate to be tested and a solution of a derivative corresponding to the meningococcal polysaccharide conjugate to be tested as Samples 1 and 3; and 2) centrifugation: additionally adding the solution of the meningococcal polysaccharide conjugate to be tested and the solution of the derivative corresponding to the meningococcal polysaccharide conjugate to be tested to a centrifugal tube; and adding a sodium deoxycholate solution to each centrifugal tube, standing for 30 min in an ice bath, then adding a hydrochloric acid solution, fully shaking, centrifuging, and collecting a supernatant from each centrifugal tube, as Samples 2 and 4; 3) calculating the polysaccharide concentration; and 4) calculating the free polysaccharide content. Through the present invention, the free polysaccharide content in meningococcal Groups A, C, W135, and Y polysaccharide conjugate can be accurately and conveniently determined, so as to evaluate the quality of a product.

Description

一种脑膜炎球菌多糖结合物中游离多糖含量的测定方法 技术领域  Method for determining free polysaccharide content in meningococcal polysaccharide conjugates
本发明属于生物技术领域, 涉及一种游离多糖的测定方法, 具体涉及一 种八、 C、 W135、 Y群脑膜炎球菌多糖结合物中游离多糖含量的测定方法。 背景技术  The invention belongs to the field of biotechnology, and relates to a method for determining a free polysaccharide, in particular to a method for determining the content of free polysaccharide in a polysaccharide combination of eight, C, W135 and Y meningococcus. Background technique
脑膜炎球菌感染是引起儿童细菌性脑膜炎和爆发性败血症的首要致病 菌。 据统计, 全球每年流行性脑膜炎发病人数约为 50万, 尤其是发展中国家 发病率较高。 世界范围内, 大部分脑膜炎疾病都是由 A群、 B群、 C群、 Y群 和 W135群脑膜炎球菌引起的, 而接种安全有效的疫苗是预防和控制脑膜炎的 理想措施。  Meningococcal infection is the leading cause of bacterial meningitis and fulminant sepsis in children. According to statistics, the annual incidence of meningococcal meningitis in the world is about 500,000, especially in developing countries. Worldwide, most meningitis diseases are caused by meningococcal bacteria such as group A, group B, group C, group Y and group W135, and safe and effective vaccination is an ideal measure to prevent and control meningitis.
目前, 在国内外上巿的脑膜炎疫苗主要有多糖疫苗和多糖结合疫苗两大 类, 其中: 多糖疫苗的抗原为半抗原, 是非 T细胞依赖性抗原, 其诱导的免疫 应答没有 T淋巴细胞参与, 不能产生免疫记忆, 所以 WHO曾建议流脑多糖疫 苗一般不用于 2岁以下婴、 幼儿的接种; 流脑多糖结合疫苗则是将提取的脑膜 炎球菌荚膜多糖与蛋白载体结合而成,其抗原为 T细胞依赖性抗原,其诱导的 免疫应答有 T淋巴细胞参与, 能刺激机体产生高水平抗体,增强对婴幼儿的免 疫记忆, 从而提高免疫效果。  At present, meningitis vaccines at home and abroad mainly include polysaccharide vaccines and polysaccharide conjugate vaccines, among which: the antigen of the polysaccharide vaccine is a hapten, which is a non-T cell-dependent antigen, and the immune response induced by it does not involve T lymphocytes. It is not possible to produce immune memory. Therefore, WHO has suggested that the meningococcal polysaccharide vaccine is generally not used for the inoculation of infants and young children under 2 years old. The meningococcal polysaccharide conjugate vaccine is a combination of the extracted meningococcal capsular polysaccharide and protein carrier. The antigen is a T cell-dependent antigen, and the induced immune response is involved in T lymphocytes, which can stimulate the body to produce high levels of antibodies, enhance the immune memory of infants and young children, and thereby improve the immune effect.
多糖结合疫苗中游离多糖的含量是多糖结合疫苗质量控^的关键指标之 一, 游离多糖含量超过规定限度会对疫苗临床效果产生不利的影响。 因此, 游离多糖含量是反映结合疫苗质量优劣的重要指标。 国外文献报道中有釆用 疏水层析、 HPLC法进行多糖结合物中游离多糖的测定, 但因层析过程中易受 到分子大小相近杂质的影响, 测定结果误差较大。  The content of free polysaccharide in the polysaccharide conjugate vaccine is one of the key indicators for the quality control of polysaccharide conjugate vaccine. The free polysaccharide content exceeding the prescribed limit will have an adverse effect on the clinical effect of the vaccine. Therefore, the free polysaccharide content is an important indicator reflecting the quality of the combined vaccine. In foreign literature reports, hydrophobic chromatography and HPLC methods were used to determine the free polysaccharides in polysaccharide conjugates. However, due to the influence of similar molecular size on the impurities during the chromatographic process, the error of the determination results was large.
中国朱为等人在 《A群脑膜炎球菌多糖-破伤风类毒素 合物中游离多糖 测定方法的建立》 中介绍了一种利用乙醇沉淀法测定 A群脑膜炎球菌多糖-破 伤风类毒素结合物中游离多糖的方法, 但该方法操作比较繁瑣, 一个样品需 要多天才能获得结果, 同时, 对于游离多糖含量较低的样品釆用该方法检测 可能存在一定的误差。 中国专利申请 200610048876.9中公开了一种 A、 C群脑膜炎球菌多糖结 合物中游离多糖的测定方法, 此方法需向样品中加入冷酚溶液进行震荡, 但 是冷酚毒性较强, 对皮肤和粘膜有强烈的腐蚀性, 长期接触会抑制中枢神经 或损害肝、 肾的功能, 吸入苯酚也可导致头痛、 头暈、 乏力、 视物模糊、 肺 水肿等症状。 Chinese Zhu Wei et al. introduced the determination of group A meningococcal polysaccharide-tetanus toxoid by ethanol precipitation method in the establishment of a method for determination of free polysaccharide in group A meningococcal polysaccharide-tetanus toxoid. The method of free polysaccharides, but the method is cumbersome to operate. It takes several days for a sample to obtain the results. At the same time, there may be some error in the detection of samples with low free polysaccharide content. Chinese Patent Application No. 200610048876.9 discloses a method for determining a free polysaccharide of a group A and C meningococcal polysaccharide conjugate, which requires adding a cold phenol solution to the sample for shaking, but the cold phenol is more toxic, to the skin and mucous membranes. It is strongly corrosive. Long-term exposure can inhibit central nervous system or impair liver and kidney function. Inhalation of phenol can also cause headache, dizziness, fatigue, blurred vision, pulmonary edema and other symptoms.
此外, 由于多糖结合物不同, 其性质的差异也较大, 因此多糖结合疫苗 中游离多糖的测定一直是一个技术难关, 目前尚无利用脱氧胆酸钠萃取方法 测定多糖结合物中游离多糖含量的报道。 发明内容  In addition, due to the difference in polysaccharide conjugates, the difference in properties is also large. Therefore, the determination of free polysaccharides in polysaccharide conjugate vaccines has always been a technical difficulty. At present, there is no use of sodium deoxycholate extraction method to determine the content of free polysaccharides in polysaccharide conjugates. Report. Summary of the invention
本发明提供了一种克服现有方法测定游离多糖含量不足的方法, 该方法 可以准确测定 A、 C、 W135、 Y群脑膜炎球菌多糖结合物中游离多糖的含量, 操作方法简单快捷。  The invention provides a method for overcoming the lack of free polysaccharide content in the prior method, which can accurately determine the content of free polysaccharide in the polysaccharide combination of A, C, W135 and Y meningococcal polysaccharides, and the operation method is simple and rapid.
本发明提供了一种脑膜炎球菌多糖结合物中游离多糖的测定方法, 包括 以下步骤: 取样、 离心、 计算多糖浓度、 计算游离多糖含量, 其中离心时, 在脑膜炎球菌多糖结合物和待测的脑膜炎球菌多糖结合物对应的衍生物中加 入脱氧胆酸钠溶液。 :  The invention provides a method for determining a free polysaccharide of a meningococcal polysaccharide conjugate, comprising the following steps: sampling, centrifuging, calculating a polysaccharide concentration, calculating a free polysaccharide content, wherein during centrifugation, a meningococcal polysaccharide conjugate and a test are to be tested A sodium deoxycholate solution is added to the corresponding derivative of the meningococcal polysaccharide conjugate. :
优选地, 本发明提供的脑膜炎球菌多糖结合物中游离多糖的测定方法, 包括以下步骤:  Preferably, the method for determining a free polysaccharide in a meningococcal polysaccharide conjugate provided by the present invention comprises the following steps:
1 )取样: 取待检脑膜炎球菌多糖结合物 lml作为样 1, 取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 1ml作为样 3;  1) sampling: taking the meningococcal polysaccharide conjugate 1ml as sample 1, taking 1ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested as sample 3;
2 )离心: 另取脑膜炎球菌多糖结合物 lml置于 1.5ml离心管中, 取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 lml置于另一 1.5ml离心管中; 向每个 离心管加入 ΙΟΟμΙ 1%的 DOC (脱氧胆酸钠)溶液, 冰洛保持 30分钟, 后加入 0.5M HC1溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, 每个离心管 单独收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4;  2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested is placed in another 1.5 ml centrifuge tube; Add ΙΟΟμΙ 1% DOC (sodium deoxycholate) solution to the ice for 30 minutes, then add 0.5μ of 0.5M HC1 solution, shake well, centrifuge at 5000 ~ 6000rpm for 15 ~ 20 minutes, collect the supernatant separately from each centrifuge tube. Lml, wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3 )计算多糖浓度:  3) Calculate the polysaccharide concentration:
A群脑膜炎球菌多糖结合物测定磷含量, 通过磷含量计算样 1、样 2、样 3、 样 4的多糖浓度; C群、 W135群、 Y群脑膜炎球菌多糖结合物测定唾液酸含量, 通过唾液酸含量计算样 1、 样 2、 样 3、 样 4的多糖浓度, 样 1、 样 2、 样 3、 样 4 的多糖浓度分别为 Cl、 C2、 C3、 C4。 Group A meningococcal polysaccharide conjugates were used to determine the phosphorus content, and the phosphorus content was used to calculate the polysaccharide concentrations of sample 1, sample 2, sample 3, and sample 4; group C, group W135, and group Y meningococcal polysaccharide conjugates were used to determine the sialic acid content. The polysaccharide concentrations of Sample 1, Sample 2, Sample 3, and Sample 4 were calculated from the sialic acid content, and the polysaccharide concentrations of Sample 1, Sample 2, Sample 3, and Sample 4 were respectively Cl, C2, C3, and C4.
4 )计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content
P=— X 100%, H=— ÷ P x 画%。  P=—X 100%, H=— ÷ P x draw %.
C3 CI  C3 CI
所述脑膜炎球菌多糖结合物为 A群、 C群、 W135群或 Y群脑膜炎球菌 多糖结合物。  The meningococcal polysaccharide conjugate is a group A, group C, group W135 or group Y meningococcal polysaccharide conjugate.
进一步优选, 本发明提供的一种 A群脑膜炎球菌多糖结合物中游离多糖 含量的测定方法, 包括以下步骤:  Further preferably, the method for determining the free polysaccharide content of the group A meningococcal polysaccharide conjugate provided by the invention comprises the following steps:
1)取样: 取待检脑膜炎球菌多糖结合物 1ml作为样 1,取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 1ml作为样 3;  1) Sampling: Take 1 ml of the meningococcal polysaccharide conjugate to be tested as sample 1, and take 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested as sample 3;
2)离心: 另取脑膜炎球菌多糖结合物 1ml置于 1.5ml离心管中,取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 1.5ml离心管中; 向每 个离心管加入 ΙΟΟμΙ 1%的脱氧胆酸钠溶液,冰洛保持 30分钟,,后加入 0.5Μ 盐 酸溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, 每个离心管单独 收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4;  2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested is placed in another 1.5 ml centrifuge tube; Add ΙΟΟμΙ 1% sodium deoxycholate solution to the tube for 30 minutes, then add 0.5 μl of hydrochloric acid solution to 25 μl, shake well, centrifuge at 5000 ~ 6000 rpm for 15-20 minutes, and collect 15 ml of supernatant from each centrifuge tube. Wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3)计算多糖浓度: A群脑膜炎球菌多糖结合物测定磷含量, 按照 "A群 多糖浓度=磷含量 /0.08", 计算样 1、 样 2、 样 3、 样 4的多糖浓度, 样 1、 样 2、 样 3、 样 4的多糖浓度分别为 Cl、 C2、 C3、 C4;  3) Calculate the concentration of polysaccharide: Group A meningococcal polysaccharide conjugate to determine the phosphorus content, according to "A group polysaccharide concentration = phosphorus content / 0.08", calculate the concentration of polysaccharides of sample 1, sample 2, sample 3, sample 4, sample 1, Sample 2, sample 3, sample 4 polysaccharide concentration is Cl, C2, C3, C4;
4)计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P= ― X 100%, H=— ÷ P X 100%。  P= ― X 100%, H=— ÷ P X 100%.
C3 C1  C3 C1
所述 A群多糖浓度 =磷含量 /0.08中公式及公式中的系数 0.08参考自 《疫 苗学》, 张延龄著。  The group A polysaccharide concentration = phosphorus content / 0.08 in the formula and the coefficient in the formula 0.08 reference from "Embrane Miao", Zhang Yanling.
进一步优选, 本发明提供的一种 C群脑膜炎球菌多糖结合物中游离多糖 含量的测定方法, 包括以下步骤:  Further preferably, the method for determining the free polysaccharide content of the group C meningococcal polysaccharide conjugate provided by the invention comprises the following steps:
1)取样: 取待检脑膜炎球菌多糖结合物 1ml作为样 1 ,取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 lml作为样 3;  1) Sampling: Take 1 ml of the meningococcal polysaccharide conjugate to be tested as sample 1, and take the lml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be sample 3;
2)离心: 另取脑膜炎球菌多糖结合物 lml置于 1.5ml离心管中,取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 1.5ml离心管中; 向每 个离心管加入 ΙΟΟμΙ 1%的脱氧胆酸钠溶液,冰浴保持 30分钟,'后加入 0.5Μ盐 酸溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, 每个离心管单独 收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4; 2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube for the brain to be examined. 1 ml of the derivative solution corresponding to the Mesangococcus polysaccharide conjugate was placed in another 1.5 ml centrifuge tube; ΙΟΟμΙ 1% sodium deoxycholate solution was added to each centrifuge tube, and the ice bath was kept for 30 minutes, and then 0.5 Μ hydrochloric acid was added. Solution 25μ1, fully shaken, centrifuged at 5000 ~ 6000rpm for 15 ~ 20 minutes, each supernatant tube separately collected 1ml of the supernatant, wherein the supernatant of the combination is sample 2, the supernatant of the derivative is sample 4;
3)计算多糖浓度: C群脑膜炎球菌多糖结合物测定唾液酸含量, 按照 "C 群多糖浓度 =唾液酸含量 /0.8", 计算样 1、样 2、样 3、样 4 ^多糖浓度, 样 1、 样 2、 样 3、 样 4的多糖浓度分别为 Cl、 C2、 C3、 C4;  3) Calculate the concentration of polysaccharide: Group C meningococcal polysaccharide conjugate to determine the sialic acid content, according to "C group polysaccharide concentration = sialic acid content / 0.8", calculate the sample 1, sample 2, sample 3, sample 4 ^ polysaccharide concentration, sample 1, sample 2, sample 3, sample 4 polysaccharide concentration is Cl, C2, C3, C4;
4)计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P= — X 100%, Η=— ÷ Ρ χ 100%。  P= — X 100%, Η=— ÷ Ρ χ 100%.
C3 CI  C3 CI
所述 C群多糖浓度 =唾液酸含量 /0.8中公式及公式中的系数参考自《疫苗 学》, 张延龄著。  The C group polysaccharide concentration = sialic acid content / 0.8 in the formula and the coefficient in the formula are referenced from "Vaccine", Zhang Yanling.
进一步优选, 本发明提供的一种 W135群脑膜炎球菌多糖结合物中游离 多糖含量的测定方法, 包括以下步骤:  Further preferably, the method for determining the free polysaccharide content of the W135 group meningococcal polysaccharide conjugate provided by the invention comprises the following steps:
1)取样: 取待检脑膜炎球菌多糖结合物 1ml作为样 1,取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 1ml作为样 3;  1) Sampling: Take 1 ml of the meningococcal polysaccharide conjugate to be tested as sample 1, and take 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested as sample 3;
2)离心: 另取脑膜炎球菌多糖结合物 1ml置于 1.5ml离心管中,取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 1.5ml离心管中; 向每 个离心管加入 ΙΟΟμΙ 1%的脱氧胆酸钠溶液,冰洛保持 30分钟,后加入 0.5Μ 盐 酸溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, '每个离心管单独 收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4;  2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested is placed in another 1.5 ml centrifuge tube; Add ΙΟΟμΙ 1% sodium deoxycholate solution to the tube for 30 minutes, then add 0.5 μl of hydrochloric acid solution to 25 μl, shake well, centrifuge at 5000 ~ 6000 rpm for 15-20 minutes, and collect 1 ml of supernatant from each centrifuge tube. Wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3)计算多糖浓度: W135群脑膜炎球菌多糖结合物测定唾液酸含量, 按照 "W135群多糖浓度 =唾液酸含量 /0.56" , 计算样 1、 样 2、 样 3、 样 4的多糖 浓度, 样 1、 样 2、 样 3、 样 4的多糖浓度分别为 Cl、 C2、 C3、 C4;  3) Calculate the concentration of polysaccharide: Determine the sialic acid content of the W135 group meningococcal polysaccharide conjugate, and calculate the polysaccharide concentration of sample 1, sample 2, sample 3, sample 4 according to "W135 group polysaccharide concentration = sialic acid content / 0.56". 1, sample 2, sample 3, sample 4 polysaccharide concentration is Cl, C2, C3, C4;
4)计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P= ― X 100%, Η=— ÷ Ρ χ 100%。  P= ― X 100%, Η=— ÷ Ρ χ 100%.
C3 CI  C3 CI
所述 W135群多糖浓度 =磷含量 /0.56中公式及公式中的系数 0.56参考自 《疫苗学》, 张延龄著。 进一步优选, 本发明提供的一种 Y群脑膜炎球菌多糖结合物中游离多糖 含量的测定方法, 包括以下步骤: The W135 group polysaccharide concentration = phosphorus content / 0.56 formula and the coefficient of the formula 0.56 are referenced from "vaccine", Zhang Yanling. Further preferably, the method for determining the free polysaccharide content of the Y group meningococcal polysaccharide conjugate provided by the invention comprises the following steps:
1)取样: 取待检脑膜炎球菌多糖结合物 1ml作为样 1 ,取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 1ml作为样 3;  1) Sampling: Take 1 ml of meningococcal polysaccharide conjugate to be tested as sample 1, and take 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be sample 3;
2)离心: 另取脑膜炎球菌多糖结合物 1ml置于 1.5ml离心管中,取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 1.5ml离心管中; 向每 个离心管加入 ΙΟΟμΙ 1%的脱氧胆酸纳溶液,冰浴保持 30分钟,后加入 0.5Μ 盐 酸溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, 每个离心管单独 收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4;  2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested is placed in another 1.5 ml centrifuge tube; Add ΙΟΟμΙ 1% sodium deoxycholate solution to the tube for 30 minutes, then add 0.5 μl of hydrochloric acid solution to 25 μl, shake well, centrifuge at 5000-6000 rpm for 15-20 minutes, and collect 1 ml of supernatant from each centrifuge tube. The conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3)计算多糖浓度: Y群脑膜炎球菌多糖结合物测定唾液酸含量, 按照 "Y 群多糖浓度 =唾液酸含量 /0.56", 计算样 1、 样 2、 样 3、 样 4的多糖浓度, 样 1、 样 2、 样 3、 样 4的多糖浓度分别为 Cl、 C2、 C3、 C4;  3) Calculate the concentration of polysaccharide: Y group meningococcal polysaccharide conjugate to determine the sialic acid content, according to "Y group polysaccharide concentration = sialic acid content / 0.56", calculate the concentration of polysaccharides of sample 1, sample 2, sample 3, sample 4, sample 1, sample 2, sample 3, sample 4 polysaccharide concentration is Cl, C2, C3, C4;
4)计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P= ― X 100%, H=— ÷ P x l00%。  P= ― X 100%, H=— ÷ P x l00%.
C3 CI  C3 CI
所述 W135群多糖浓度 =磷含量 /0.56中公式及公式中的系数 0.56参考自 《疫苗学》(张延龄著)。  The W135 group polysaccharide concentration = phosphorus content / 0.56 formula and the coefficient in the formula 0.56 reference from "vaccine" (Zhang Yanling).
其中:  among them:
所述 DOC的浓度单位为 l%(lg/100ml);  The concentration unit of the DOC is 1% (lg/100 ml);
所述盐酸的浓度单位为 mol/L, 简写为 M;  The concentration unit of the hydrochloric acid is mol/L, abbreviated as M;
所述多糖结合物中磷含量是釆用 2010年版《中国药典》 第三部附录 VIIA 中的磷测定法测定, 多糖结合物中唾液酸含量是釆用 2010年版《中国药典》 第三部附录 VIC中的间苯二酚显色法测定。  The phosphorus content in the polysaccharide conjugate is determined by the phosphorus assay in the third edition of Appendix VIIA of the 2010 edition of the Chinese Pharmacopoeia. The sialic acid content in the polysaccharide conjugate is used in the 2010 edition of the Chinese Pharmacopoeia. Determination by resorcinol colorimetry.
本发明的有益效果是:  The beneficial effects of the invention are:
1、 本发明提供了一种准确、 快速测定 A群、 C群、 W135群和 Y群脑膜炎 球菌多糖结合物中游离多糖含量的方法, 从而评价制品质量。  1. The present invention provides a method for accurately and rapidly determining the content of free polysaccharides in a combination of group A, group C, group W135 and group Y meningococcus, thereby evaluating the quality of the product.
2、 脱氧胆酸钠, 分子式: C24H40O4 ' Na, 分子量: 414.56, 性状: 白色 结晶性粉末。 类似胆汁气味, 有强烈苦味。 易吸湿。 易溶于水, 微溶于无水 醇, 不溶于醚。 低毒, 半数致死量 (大鼠, 经口) 1370mg/kg。 有刺激性。 本发明利用 DOC (脱氧胆酸钠)在酸性条件下可沉淀蛋白质的特性, 在 样品经 DOC处理并高速离心后, 结合疫苗中的结合物被沉淀而多糖在同样条 件下仍然留在上清中, 以此将结合多糖与游离多糖分开, 通过分别测定离心 上清液与原液的多糖含量, 即可计算出游离多糖的含量。 2, sodium deoxycholate, molecular formula: C 24 H4 0 O 4 ' Na, molecular weight: 414.56, traits: white crystalline powder. Similar to bile smell, it has a strong bitter taste. Easy to absorb moisture. Soluble in water, slightly soluble in anhydrous alcohol, insoluble in ether. Low toxicity, half lethal dose (rat, oral) 1370mg/kg. Irritating. The invention utilizes the characteristics of DOC (sodium deoxycholate) which can precipitate proteins under acidic conditions. After the sample is treated by DOC and centrifuged at high speed, the conjugate in the conjugate vaccine is precipitated and the polysaccharide remains in the supernatant under the same conditions. In this way, the bound polysaccharide is separated from the free polysaccharide, and the content of the free polysaccharide can be calculated by separately measuring the polysaccharide content of the centrifugation supernatant and the stock solution.
3、 与专利 200610048876.9相比, 虽然回收率相差不大, 但是克服了冷酚 对人体危害较大这一不利因素, 同时该方法不仅适用于 A群、 C群脑膜炎球菌 多糖结合物游离多糖含量的测定, 也能快速、 准确地测定 W135、 Y群脑膜炎 球菌多糖结合物中游离多糖含量。 具体实施方式  3. Compared with the patent 200610048876.9, although the recovery rate is not much different, it overcomes the unfavorable factor that the cold phenol is harmful to the human body. At the same time, the method is not only applicable to the free polysaccharide content of the polysaccharide combination of group A and group C meningococcus. The determination of free polysaccharides in W135, Y meningococcal polysaccharide conjugates can also be determined quickly and accurately. detailed description
以下实施例用于说明本发明, 但不应用来限制本发明的范围。  The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
本发明中回收率 P在 80-120%之间, 高于 90%意味着准确度高。  In the present invention, the recovery ratio P is between 80 and 120%, and higher than 90% means high accuracy.
实施例 1 Example 1
1、 取样: 取待检 A群脑膜炎球菌多糖结合物 1ml作为样 1 , 取该 A群脑膜 炎球菌多糖结合物对应的衍生物溶液 lml作为样 3;  1. Sampling: Take 1ml of group A meningococcal polysaccharide conjugate to be tested as sample 1 and take the lml of the derivative solution corresponding to the group A meningococcal polysaccharide conjugate as sample 3;
2、 离心: 另取该 A群脑膜炎球菌多糖结合物 lml置于 1.5ml离心管中, 取 该待检 A群脑膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 1.5ml离心 管中; 分别向每个离心管加入 ΙΟΟμΙ 1%的 DOC溶液, 冰洛保持 30分钟, 后加 入 0.5M HCL溶液 25μ1, 充分振荡, 5000rpm离心 15 ~ 20分钟, 每个离心管单 独收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4。  2. Centrifugation: Take another 1 ml of the group A meningococcal polysaccharide conjugate in a 1.5 ml centrifuge tube, and take 1 ml of the derivative solution corresponding to the group A meningococcal polysaccharide conjugate to be tested in another 1.5 ml centrifuge tube. Add ΙΟΟμΙ 1% DOC solution to each centrifuge tube, keep icolo for 30 minutes, then add 0.5μH0.5 solution to 25μ1, shake well, centrifuge at 5000rpm for 15-20 minutes, collect supernatant 1ml separately from each centrifuge tube. , wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4.
3、 计算多糖浓度: 测定样 1、 样 2、 样 3、 样 4的磷含量, 按照公式 "A群 多糖浓度=磷含量 /0.08" 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3和 C4。  3. Calculate the polysaccharide concentration: Determine the phosphorus content of sample 1, sample 2, sample 3, sample 4, and calculate the polysaccharide concentration of sample 1, sample 2, sample 3, sample 4 according to the formula "group A polysaccharide concentration = phosphorus content / 0.08". Cl, C2, C3 and C4.
其中样本中磷含量是釆用 2010年版《中国药典》 第三部附录 VIIA中的磷 测定法测定。  The phosphorus content in the sample was determined by the phosphorus method in the third edition of Appendix VIIA of the 2010 edition of the Chinese Pharmacopoeia.
4、 计算游离多糖含量: 其中 P为回收率, H为游离多糖含量
Figure imgf000008_0001
4. Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
Figure imgf000008_0001
5、 运用本发明实施例 1提供的方法测定 3批脑膜炎球菌 A群多糖结合物样 , 检测结果详见表 1。 5, using the method provided in Example 1 of the present invention to determine three batches of meningococcal group A polysaccharide conjugate samples The test results are shown in Table 1.
表 1: 3批脑膜炎球菌 A群多糖结合物样品测定结果  Table 1: Results of three batches of meningococcal group A polysaccharide conjugate samples
Figure imgf000009_0001
Figure imgf000009_0001
表 1结果显示: 本发明提供的方法能够准确测定脑膜炎球菌 A群多糖结合 物中游离多糖含量。  The results in Table 1 show that: The method provided by the present invention can accurately determine the content of free polysaccharide in the polysaccharide combination of meningococcal group A.
实施例 2 Example 2
1、 取样: 取待检 C群脑膜炎球菌多糖结合物 1ml作为样 1, 取该 C群 脑膜炎球菌多糖结合物对应的衍生物溶液 1ml作为样 3;  1. Sampling: Take 1ml of group C meningococcal polysaccharide conjugate as sample 1, take 1ml of the derivative solution corresponding to the group C meningococcal polysaccharide conjugate as sample 3;
2、 离心: 另取该 C群脑膜炎球菌多糖结合物 lml置于 1.5ml离心管中, 取该待检 C群脑膜炎球菌多糖结合物对应的衍生物溶液 lml置于另一 1.5ml 离心管中;分别向每个离心管加入 ΙΟΟμΙ 1%的 DOC溶液,冰浴保持 30分钟, 后加入 0.5M HCL溶液 25μ1, 充分振荡, 5000rpm离心 15 ~ 20分钟, 每个离 心管单独收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4;  2. Centrifugation: Take another 1 ml of the group C meningococcal polysaccharide conjugate in a 1.5 ml centrifuge tube, and take 1 ml of the derivative solution corresponding to the group C meningococcal polysaccharide conjugate to be tested in another 1.5 ml centrifuge tube. Add ΙΟΟμΙ 1% DOC solution to each centrifuge tube, hold for 30 minutes in ice bath, add 25μ1 of 0.5M HCL solution, shake well, centrifuge at 5000rpm for 15-20 minutes, collect supernatant 1ml separately from each centrifuge tube. , wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3、 计算多糖浓度: 测定样 1、 样 2、 样 3、 样 4的唾液酸含量, 按照公 式 "C群多糖浓度 =唾液酸含量 /0.8" 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3、 C4;  3. Calculate the concentration of polysaccharide: Determine the sialic acid content of sample 1, sample 2, sample 3, sample 4, and calculate the sample 1, sample 2, sample 3, sample 4 according to the formula "C group polysaccharide concentration = sialic acid content / 0.8" Polysaccharide concentration Cl, C2, C3, C4;
其中样本中唾液酸的含量是釆用 2010年版《中囯药典》 第三部附录 VIC 中的唾液酸含量测定法测定。  The content of sialic acid in the sample was determined by the sialic acid content determination method in the third edition of Appendix VI of the 2010 edition of the Chinese Pharmacopoeia.
4、 计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4. Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P=— X 100%, Η=— ÷ Ρ χ 100%。 P=—X 100%, Η=— ÷ Ρ χ 100%.
C3 CI  C3 CI
5、 运用本发明实施例 2提供的方法测定 3批脑膜炎球菌 C群多糖结合 物样品, 检测结果见表 2: 表 2: 3批脑膜炎球菌 C群多糖结合物样品测定结果 5. The samples of the three groups of meningococcal group C polysaccharide conjugates were determined by the method provided in Example 2 of the present invention, and the test results are shown in Table 2: Table 2: Results of three batches of meningococcal group C polysaccharide conjugate samples
Figure imgf000010_0001
Figure imgf000010_0001
表 2结果显示: 本方法能够准确测定脑膜炎球菌 C群多糖结合物中游离多 糖含量。  The results in Table 2 show that: This method can accurately determine the free polysaccharide content of the meningococcal group C polysaccharide combination.
实施例 3 Example 3
1、 取样: 取待检 W135群脑膜炎球菌多糖结合物 1ml作为样 1, 取该 W135群脑膜炎球菌多糖结合物对应的衍生物溶液 1ml作为样 3;  1. Sampling: Take 1ml of the W135 group meningococcal polysaccharide conjugate as sample 1, and take 1ml of the derivative solution corresponding to the W135 group meningococcal polysaccharide conjugate as sample 3;
2、 离心: 另取该 W135群脑膜炎球菌多糖结合物 lml置于 1.5ml离心管 中, 取该待检 W135群脑膜炎球菌多糖结合物对应的衍生物溶液 lml置于另 一 1.5ml离心管中; 分别向每个离心管加入 ΙΟΟμΙ 1%的 DOC溶液, 冰浴保 持 30分钟, 后加入 0.5Μ HCL溶液 25μ1, 充分振荡, 5000rpm离心 15 ~ 20 分钟, 每个离心管单独收集上清液 lml, 其中结合物上清液为样 2, 衍生物 上清液为样 4;  2. Centrifugation: Take another 1 ml of the W135 group meningococcal polysaccharide conjugate in a 1.5 ml centrifuge tube, and take 1 ml of the derivative solution corresponding to the W135 group meningococcal polysaccharide conjugate to be placed in another 1.5 ml centrifuge tube. Add ΙΟΟμΙ 1% DOC solution to each centrifuge tube, hold for 30 minutes in an ice bath, then add 0.5 μL of 0.5 Μ HCL solution, shake well, centrifuge at 5000 rpm for 15-20 minutes, and collect supernatant 1 ml separately from each centrifuge tube. , wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3、 计算多糖浓度: 测定样 1、 样 2、 样 3、 样 4的唾液酸含量(样本中 唾液酸的含量测定法同实施例 2 ), 按照公式 "W135 群多糖浓度 =唾液酸含 量 /0.56" 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3、 C4;  3. Calculate the concentration of polysaccharide: sialic acid content of sample 1, sample 2, sample 3, sample 4 (the sialic acid content in the sample is determined in the same manner as in Example 2), according to the formula "W135 group polysaccharide concentration = sialic acid content / 0.56 "Computation sample 1, sample 2, sample 3, sample 4 polysaccharide concentration Cl, C2, C3, C4;
4、 计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4. Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P=— X 100%, Η=— ÷ Ρ χ 100%。  P=—X 100%, Η=— ÷ Ρ χ 100%.
C3 CI  C3 CI
5、运用本发明实施例 1提供的方法测定 3批脑膜炎球菌 W135群多糖结 合物样品, 检测结果见表 3:  5. Three batches of meningococcal W135 group polysaccharide composition samples were determined by the method provided in Example 1 of the present invention, and the test results are shown in Table 3:
表 3: 3批脑膜炎球菌 W135群多糖结合物样品测定结果  Table 3: Three batches of meningococcal bacteria W135 group polysaccharide conjugate sample determination results
Figure imgf000010_0002
20100407 233.7 22.9 196.3 189.5 96.5 10.2
Figure imgf000010_0002
20100407 233.7 22.9 196.3 189.5 96.5 10.2
20100412 286.5 26.0 225.6 218.9 97.0 9.4 表 3结果显示: 本方法能够准确测定脑膜炎球菌 W135群多糖结合物中游 离多糖含量。 20100412 286.5 26.0 225.6 218.9 97.0 9.4 Table 3 shows that: This method can accurately determine the free polysaccharide content of meningococcal W135 group polysaccharide conjugate.
实施例 4 Example 4
1、 取样: 取待检 Y群脑膜炎球菌多糖结合物 lml作为样 1 , 取该 Y群 脑膜炎球菌多糖结合物对应的衍生物溶液 lml作为样 3;  1. Sampling: Take the group Y meningococcal polysaccharide conjugate lml as sample 1 and take the lml of the derivative solution corresponding to the group Y meningococcal polysaccharide conjugate as sample 3;
2、 离心: 另取该 Y群脑膜炎球菌多糖结合物 lml置于 1.5ml离心管中, 取该待检 Y群脑膜炎球菌多糖结合物对应的衍生物溶液 lml置于另一 1.5ml 离心管中;分别向每个离心管加入 ΙΟΟμΙ 1%的 DOC溶液,冰洛保持 30分钟, 后加入 0.5M HCL溶液 25μ1, 充分振荡, 5000rpm离心 15 ~ 20分钟, 每个离 心管单独收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4;  2. Centrifugation: Take another 1 ml of the Y group meningococcal polysaccharide conjugate in a 1.5 ml centrifuge tube, and take 1 ml of the derivative solution corresponding to the Y group meningococcal polysaccharide conjugate to be placed in another 1.5 ml centrifuge tube. Add ΙΟΟμΙ 1% DOC solution to each centrifuge tube, keep ice for 30 minutes, then add 0.5μH0.5 solution to 25μ1, shake well, centrifuge at 5000rpm for 15-20 minutes, collect supernatant 1ml separately from each centrifuge tube. , wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3、 计算多糖浓度: 测定样 1、 样 2、 样 3、 样 4的唾液酸含量(样本中 唾液酸的含量测定法同实施例 2 ), 按照公式 "Y群多糖浓度 =唾液酸含量 /0.56" 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3、 C4;  3. Calculate the concentration of polysaccharide: Determination of the sialic acid content of sample 1, sample 2, sample 3, sample 4 (the determination method of sialic acid in the sample is the same as in Example 2), according to the formula "Y group polysaccharide concentration = sialic acid content / 0.56 "Computation sample 1, sample 2, sample 3, sample 4 polysaccharide concentration Cl, C2, C3, C4;
4、 计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4. Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P=— X 100%, H=— ÷ P x 100%。  P=—X 100%, H=— ÷ P x 100%.
C3 CI  C3 CI
5、 运用本发明实施例 1提供的方法测定 3批脑膜炎球菌 Y群多糖结合 物样品, 检测结果见表 4:  5. Using the method provided in Example 1 of the present invention, three batches of meningococcal Y group polysaccharide conjugate samples were determined, and the test results are shown in Table 4:
表 4: 3批脑膜炎球菌 Y群多糖结合物样品测定结果  Table 4: Results of three batches of meningococcal Y group polysaccharide conjugate samples
Figure imgf000011_0001
Figure imgf000011_0001
表 4结果显示: 本方法能够准确测定脑膜炎球菌 Y群多糖结合物中游离多 糖含量。 实施例 5 The results in Table 4 show that: This method can accurately determine the free polysaccharide content of the meningococcal Y group polysaccharide combination. Example 5
1、 取样: 取待检 W135群脑膜炎球菌多糖结合物 1ml作为样 1 , 取该 W135群脑膜炎球菌多糖结合物对应的衍生物溶液 1ml作为样 3;  1. Sampling: Take 1ml of the W135 group meningococcal polysaccharide conjugate as sample 1 and take 1ml of the derivative solution corresponding to the W135 group meningococcal polysaccharide conjugate as sample 3;
2、 离心: 另取该 W135群脑膜炎球菌多糖结合物 lml置于 1.5ml离心管 中, 取该待检 W135群脑膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另 一 1.5ml离心管中; 向每个离心管加入 ΙΟΟμΙ 1%的 DOC溶液, 冰浴保持 30 分钟, 后加入 0.5M HCL溶液 25μ1, 充分振荡, 6000rpm离心 15 ~ 20分钟, 每个离心管单独收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液 为样 4;  2. Centrifugation: Another 1 ml of the W135 group meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the W135 group meningococcal polysaccharide conjugate is placed in another 1.5 ml centrifuge tube. Add ΙΟΟμΙ 1% DOC solution to each centrifuge tube, keep in ice bath for 30 minutes, then add 0.5μH 0.5ml HCL solution, shake well, centrifuge at 6000rpm for 15-20 minutes, and collect 1ml of supernatant from each centrifuge tube. Wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3、 计算多糖浓度: 测定样 1、 样 2、 样 3、 样 4的唾液酸含量 (样本中 唾液酸的含量测定法同实施例 2 ), 按照公式 "W135 群多糖浓度 =唾液酸含 量 /0.56,, 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3、 C4;  3. Calculate the concentration of polysaccharide: sialic acid content of sample 1, sample 2, sample 3, sample 4 (the sialic acid content in the sample is determined in the same manner as in Example 2), according to the formula "W135 group polysaccharide concentration = sialic acid content / 0.56 ,, calculate the concentration of the sample 1, sample 2, sample 3, sample 4, Cl, C2, C3, C4;
4、 计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4. Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P=— X 100%, Η=— ÷ Ρ χ 100%。  P=—X 100%, Η=— ÷ Ρ χ 100%.
C3 CI  C3 CI
5、运用本发明实施例 1提供的方法测定 3批脑膜炎球菌 W135群多糖结 合物样品, 检测结果见表 5:  5. Three batches of meningococcal W135 group polysaccharide composition samples were determined by the method provided in Example 1 of the present invention, and the test results are shown in Table 5:
表 5 : 3批脑膜炎球菌 W135群多糖结合物样品测定结果  Table 5: Results of three batches of meningococcal W135 group polysaccharide conjugate samples
Figure imgf000012_0001
Figure imgf000012_0001
表 5结果显示: 本方法能够准确测定脑膜炎球菌 W135群多糖结合物中游 离多糖含量。  The results in Table 5 show that: This method can accurately determine the free polysaccharide content of the polysaccharide conjugate of meningococcal W135 group.
实施例 ό Example ό
1、 取样: 取待检 Υ群脑膜炎球菌多糖结合物 lml作为样 1, 取该 Y群 脑膜炎球菌多糖结合物对应的衍生物溶液 lml作为样 3;  1. Sampling: Take 1ml of the meningococcal polysaccharide conjugate of the sputum group as sample 1, and take the lml of the derivative solution corresponding to the Y group meningococcal polysaccharide conjugate as sample 3;
2、 离心: 另取该 Y群脑膜炎球菌多糖结合物 lml置于 1.5ml离心管中, 取该待检 Y群脑膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 1.5ml 离心管中; 向每个离心管加入 100μ1 1%的 DOC溶液, 冰洛保持 30分钟, 后 加入 0.5M HCL溶液 25μ1, 充分振荡, 6000rpm离心 15 ~ 20分钟, 每个离心 管单独收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4; 2, centrifugation: Another group of Y group meningococcal polysaccharide conjugate lml placed in a 1.5ml centrifuge tube, Take 1 ml of the derivative solution corresponding to the Y group meningococcal polysaccharide conjugate to be placed in another 1.5 ml centrifuge tube; add 100 μl 1% DOC solution to each centrifuge tube, keep ice for 30 minutes, then add 0.5 25 μl of M HCL solution, fully shaken, centrifuged at 6000 rpm for 15-20 minutes, and each supernatant was separately collected 1 ml of the supernatant, wherein the supernatant of the conjugate was sample 2, and the supernatant of the derivative was sample 4;
3、 计算多糖浓度: 测定样 1、 样 2、 样 3、 样 4的唾液酸含量 (样本中 唾液酸的含量测定法同实施例 2 ), 按照公式 "Y群多糖浓度 =唾液酸含量 /0.56" 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3、 C4;  3. Calculate the concentration of polysaccharide: Determination of the sialic acid content of sample 1, sample 2, sample 3, sample 4 (the determination method of sialic acid in the sample is the same as in Example 2), according to the formula "Y group polysaccharide concentration = sialic acid content / 0.56 "Computation sample 1, sample 2, sample 3, sample 4 polysaccharide concentration Cl, C2, C3, C4;
4、 计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4. Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P=— X 100%, Η=— ÷ Ρ χ 100%。 P=—X 100%, Η=— ÷ Ρ χ 100%.
C3 CI  C3 CI
5、 运用本发明实施例 1提供的方法测定 3批脑膜炎球菌 Y群多糖结合 物样品, 检测结果见表 6:  5. Three batches of meningococcal Y group polysaccharide conjugate samples were determined by the method provided in Example 1 of the present invention, and the test results are shown in Table 6:
表 6: 3批脑膜炎球菌 Υ群多糖结合物样品测定结果  Table 6: Results of three batches of meningococcal sputum polysaccharide conjugate samples
Figure imgf000013_0001
Figure imgf000013_0001
表 6的结果显示: 本方法能够准确测定脑膜炎球菌 Υ群多糖结合物中游离 多糖含量。 工业实用性  The results in Table 6 show that: This method can accurately determine the free polysaccharide content of the meningococcal polysaccharide combination. Industrial applicability
本发明利用脱氧胆酸钠 (DOC )在酸性条件下可沉淀蛋白质的特性, 在 样品经 DOC处理并高速离心后, 结合疫苗中的结合物被沉淀而多糖在同样条 件下仍然留在上清中, 以此将结合多糖与游离多糖分开, 通过分别测定离心 上清液与原液的多糖含量, 即可计算出游离多糖的含量。 该方法可准确、 快 速测定 Α群、 C群、 W135群和 Y群脑膜炎球菌多糖结合物中獰离多糖的含量, 从而评价制品质量。  The invention utilizes the characteristics of sodium deoxycholate (DOC) to precipitate proteins under acidic conditions. After the sample is treated by DOC and centrifuged at high speed, the conjugate in the conjugate vaccine is precipitated and the polysaccharide remains in the supernatant under the same conditions. In this way, the bound polysaccharide is separated from the free polysaccharide, and the content of the free polysaccharide can be calculated by separately measuring the polysaccharide content of the centrifugation supernatant and the stock solution. The method can accurately and quickly determine the content of the polysaccharides in the polysaccharide combination of the sputum group, the C group, the W135 group and the Y group meningococcus, thereby evaluating the quality of the product.

Claims

权 利 要 求 书 Claim
1、 一种脑膜炎球菌多糖结合物中游离多糖含量的测定方法, 包括取样、 离心、 计算多糖浓度、 计算游离多糖含量, 其特征在于, 离心时在脑膜炎球 菌多糖结合物和待测的脑膜炎球菌多糖结合物对应的衍生物中加入脱氧胆酸 钠溶液。 A method for determining a free polysaccharide content of a meningococcal polysaccharide conjugate, comprising sampling, centrifuging, calculating a polysaccharide concentration, and calculating a free polysaccharide content, characterized in that the meningococcal polysaccharide conjugate and the meninges to be tested are centrifuged A sodium deoxycholate solution is added to the derivative corresponding to the inflammatory combination of the bacterium.
2、 根据权利要求 1所述的测定方法, 其特征在于, 该脑膜炎球菌多糖结 合物选自 A群、 C群、 W135群或 Y群。  The assay method according to claim 1, wherein the meningococcal polysaccharide composition is selected from the group consisting of group A, group C, group W135 or group Y.
3、 根据权利要求 2所述的测定方法, 其特征在于, 该脑膜炎球菌多糖结 合物为 A群脑膜炎球菌多糖结合物, 该结合物中游离多糖含量的测定方法包 括以下步骤:  The method according to claim 2, wherein the meningococcal polysaccharide composition is a group A meningococcal polysaccharide conjugate, and the method for measuring the free polysaccharide content in the conjugate comprises the following steps:
1)取样: 取待检脑膜炎球菌多糖结合物 1ml作为样 1,取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 1ml作为样 3;  1) Sampling: Take 1 ml of the meningococcal polysaccharide conjugate to be tested as sample 1, and take 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested as sample 3;
2)离心: 另取脑膜炎球菌多糖结合物 1ml置于 1.5ml离心管中,取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 1.5ml离心管中; 向每 个离心管加入 ΙΟΟμΙ 1%的脱氧胆酸钠溶液,冰浴保持 30分钟,后加入 0.5Μ 盐 酸溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, 每个离心管单独 收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清.液为样 4;: 2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested is placed in another 1.5 ml centrifuge tube; Add ΙΟΟμΙ 1% sodium deoxycholate solution to the tube for 30 minutes, then add 0.5 μl of hydrochloric acid solution to 25 μl, shake well, centrifuge at 5000-6000 rpm for 15-20 minutes, and collect 1 ml of supernatant from each centrifuge tube. sample 2 was combined supernatant, the supernatant of derivatives of 4 samples;.:
3)计算多糖浓度: A群脑膜炎球菌多糖结合物测定磷含量, 按照 "A群 多糖浓度=磷含量 /0.08" , 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3、 C4;  3) Calculate the concentration of polysaccharide: Group A meningococcal polysaccharide conjugate to determine the phosphorus content, according to "group A polysaccharide concentration = phosphorus content / 0.08", calculate the concentration of the sample 1, sample 2, sample 3, sample 4, Cl, C2 C3, C4;
4)计算游离多糖含量: 其中 P为回收率, H为游离多糖含量 '
Figure imgf000014_0001
4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content'
Figure imgf000014_0001
4、 根据权利要求 2所述的测定方法, 其特征在于, 该脑膜炎球菌多糖结 合物为 C群脑膜炎球菌多糖结合物, 该结合物中游离多糖含量的测定方法包 括以下步骤:  The method according to claim 2, wherein the meningococcal polysaccharide composition is a group C meningococcal polysaccharide conjugate, and the method for measuring the free polysaccharide content in the conjugate comprises the following steps:
1)取样: 取待检脑膜炎球菌多糖结合物 1ml作为样 1 ,取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 lml作为样 3; 2)离心: 另取脑膜炎球菌多糖结合物 1ml置于 1.5ml离心管中,取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 1.5ml离心管中; 向每 个离心管加入 ΙΟΟμΙ 1%的脱氧胆酸钠溶液,冰洛保持 30分钟,后加入 0.5Μ ..盐 酸溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, 每个离心管单独 收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4; 1) Sampling: Take 1 ml of meningococcal polysaccharide conjugate to be sampled as sample 1, and take 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be sample 3; 2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested is placed in another 1.5 ml centrifuge tube; Add ΙΟΟμΙ 1% sodium deoxycholate solution to the tube, keep ice for 30 minutes, then add 0.5 Μ.. hydrochloric acid solution 25μ1, shake well, centrifuge at 5000 ~ 6000rpm for 15 ~ 20 minutes, separately collect the supernatant lml in each centrifuge tube , wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3)计算多糖浓度: C群脑膜炎球菌多糖结合物测定唾液酸含量, 按照 "C 群多糖浓度 =唾液酸含量 /0.8" , 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3、 C4;  3) Calculate the concentration of polysaccharide: Group C meningococcal polysaccharide conjugate to determine the sialic acid content, according to "C group polysaccharide concentration = sialic acid content / 0.8", calculate the concentration of the sample 1, sample 2, sample 3, sample 4, Cl, C2, C3, C4;
4)计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P=— X 100%, H=— ÷ P x 100%。  P=—X 100%, H=— ÷ P x 100%.
C3 CI  C3 CI
5、 根据杈利要求 2所述的测定方法, 其特征在于, 该脑膜炎球菌多糖结 合物为 W135群脑膜炎球菌多糖结合物, 该结合物中游离多糖含量的测定方 法包括以下步骤:  5. The method according to claim 2, wherein the meningococcal polysaccharide composition is a W135 group meningococcal polysaccharide conjugate, and the method for determining the free polysaccharide content in the conjugate comprises the following steps:
1)取样: 取待检脑膜炎球菌多糖结合物 lml作为样 1,取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 1ml作为样 3;  1) Sampling: Take 1 ml of the meningococcal polysaccharide conjugate to be tested as sample 1, and take 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested as sample 3;
2)离心: 另取脑膜炎球菌多糖结合物 lml置于 1.5ml离心管中,取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 lml置于另一 1.5ml离心管中; 向每 个离心管加入 ΙΟΟμΙ 1%的脱氧胆酸钠溶液,冰洛保持 30分钟,后加入 0.5Μ 盐 酸溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, 每个离心管单独. 收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4;  2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested is placed in another 1.5 ml centrifuge tube; Add ΙΟΟμΙ 1% sodium deoxycholate solution to the tube for 30 minutes, then add 0.5 μl hydrochloric acid solution 25 μl, shake well, centrifuge at 5000 ~ 6000 rpm for 15 ~ 20 minutes, separate each tube. Collect the supernatant lml, Wherein the conjugate supernatant is sample 2, and the derivative supernatant is sample 4;
3)计算多糖浓度: W135群脑膜炎球菌多糖结合物测定唾液酸含量, 按照 "W135群多糖浓度 =唾液酸含量 /0.56" , 计算样 1、 样 2、 样 3、 样 4的多糖 浓度 Cl、 C2、 C3、 C4;  3) Calculate the polysaccharide concentration: The sialic acid content of the W135 group meningococcal polysaccharide conjugate is determined. According to the "W135 group polysaccharide concentration = sialic acid content / 0.56", the polysaccharide concentration Cl of sample 1, sample 2, sample 3, sample 4 is calculated. C2, C3, C4;
4)计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P=— X 100%, H=— ÷ P x 100%。  P=—X 100%, H=— ÷ P x 100%.
C3 CI  C3 CI
6、 根据权利要求 2所述的测定方法, 其特征在于, 该脑膜炎球菌多糖结 合物为 Y群脑膜炎球菌多糖结合物, 该结合物中游离多糖含量的测定方法包 括以下步骤: The method according to claim 2, wherein the meningococcal polysaccharide conjugate is a group Y meningococcal polysaccharide conjugate, and the method for measuring a free polysaccharide content in the conjugate is Including the following steps:
1)取样: 取待检脑膜炎球菌多糖结合物 1ml作为样 1,取待检脑膜炎球菌 多糖结合物对应的衍生物溶液 1ml作为样 3;  1) Sampling: Take 1 ml of the meningococcal polysaccharide conjugate to be tested as sample 1, and take 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested as sample 3;
2)离心: 另取脑膜炎球菌多糖结合物 1ml置于 1.5ml离心管中,取待检脑 膜炎球菌多糖结合物对应的衍生物溶液 1ml置于另一 L5ml离心管中; 向每 个离心管加入 ΙΟΟμΙ 1%的脱氧胆酸钠溶液,冰洛保持 30分钟,后加入 0.5Μ盐 酸溶液 25μ1, 充分振荡, 5000 ~ 6000rpm离心 15 ~ 20分钟, 每个离心管单独 收集上清液 lml, 其中结合物上清液为样 2, 衍生物上清液为样 4;  2) Centrifugation: Another 1 ml of meningococcal polysaccharide conjugate is placed in a 1.5 ml centrifuge tube, and 1 ml of the derivative solution corresponding to the meningococcal polysaccharide conjugate to be tested is placed in another L5 ml centrifuge tube; Add ΙΟΟμΙ 1% sodium deoxycholate solution, keep ice for 30 minutes, then add 0.5μl hydrochloric acid solution 25μ1, shake well, centrifuge at 5000 ~ 6000rpm for 15 ~ 20 minutes, collect 15ml of supernatant separately from each centrifuge tube, where combined The supernatant is sample 2, and the derivative supernatant is sample 4;
3)计算多糖浓度: Y群脑膜炎球菌多糖结合物测定唾液酸含量, 按照 "Y 群多糖浓度 =唾液酸含量 /0.56,,, 计算样 1、 样 2、 样 3、 样 4的多糖浓度 Cl、 C2、 C3、 C4;  3) Calculate the polysaccharide concentration: Y group meningococcal polysaccharide conjugate to determine the sialic acid content, according to "Y group polysaccharide concentration = sialic acid content / 0.56,, calculate the sample 1, sample 2, sample 3, sample 4 polysaccharide concentration Cl , C2, C3, C4;
4)计算游离多糖含量: 其中 P为回收率, H为游离多糖含量  4) Calculate the free polysaccharide content: where P is the recovery rate and H is the free polysaccharide content.
P=— X 100%, Η=— ÷ Ρ χ 100%。  P=—X 100%, Η=— ÷ Ρ χ 100%.
C3 CI  C3 CI
PCT/CN2011/002180 2010-12-30 2011-12-26 Method for determining free polysaccharide content in meningococcal polysaccharide conjugate WO2012088762A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201010623626.X 2010-12-30
CN201010623626XA CN102175841A (en) 2010-12-30 2010-12-30 Method for measuring content of free polysaccharides in meningococcal polysaccharide combo

Publications (1)

Publication Number Publication Date
WO2012088762A1 true WO2012088762A1 (en) 2012-07-05

Family

ID=44519046

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2011/002180 WO2012088762A1 (en) 2010-12-30 2011-12-26 Method for determining free polysaccharide content in meningococcal polysaccharide conjugate

Country Status (2)

Country Link
CN (1) CN102175841A (en)
WO (1) WO2012088762A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102175841A (en) * 2010-12-30 2011-09-07 北京民海生物科技有限公司 Method for measuring content of free polysaccharides in meningococcal polysaccharide combo

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102735809B (en) * 2012-06-29 2015-04-29 成都欧林生物科技股份有限公司 Method for determining content of polymer conjugate in Hib conjugate vaccine
CN102809656B (en) * 2012-08-26 2014-09-03 云南沃森生物技术股份有限公司 Method for detecting content of each group of free polysaccharide in meningococcus polysaccharide conjugate vaccine finished product
CN102809655B (en) * 2012-08-26 2014-05-21 玉溪沃森生物技术有限公司 Method for determining content of polysaccharide of each group of meningococcus polysaccharide conjugate vaccine finished products
CN102830185B (en) * 2012-08-29 2013-12-11 北京民海生物科技有限公司 Determination method for sodium deoxycholate in streptococcus pneumoniae polysaccharide solution
CN103275238B (en) * 2013-06-06 2015-10-28 成都欧林生物科技股份有限公司 A kind of novel method removing protein impurities in A, C group meningitis cocci capsular polysaccharide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714354A (en) * 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
US20070065460A1 (en) * 2003-09-11 2007-03-22 Nederlands Vaccininstituut Process for producing a capsular polysaccharide for use in conjugate vaccines
CN1971266A (en) * 2006-12-06 2007-05-30 云南沃森生物技术有限公司 Method for detecting content of free polysaccharides in A, C group meningitis cocci polysaccharides combo
CN101140276A (en) * 2007-10-26 2008-03-12 兰州生物制品研究所 Method for measuring conjugate content in pneumonia combined vaccinogen liquid
CN102175841A (en) * 2010-12-30 2011-09-07 北京民海生物科技有限公司 Method for measuring content of free polysaccharides in meningococcal polysaccharide combo

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714354A (en) * 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
US20070065460A1 (en) * 2003-09-11 2007-03-22 Nederlands Vaccininstituut Process for producing a capsular polysaccharide for use in conjugate vaccines
CN1971266A (en) * 2006-12-06 2007-05-30 云南沃森生物技术有限公司 Method for detecting content of free polysaccharides in A, C group meningitis cocci polysaccharides combo
CN101140276A (en) * 2007-10-26 2008-03-12 兰州生物制品研究所 Method for measuring conjugate content in pneumonia combined vaccinogen liquid
CN102175841A (en) * 2010-12-30 2011-09-07 北京民海生物科技有限公司 Method for measuring content of free polysaccharides in meningococcal polysaccharide combo

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GUO, YUYI ET AL.: "A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Heamophilus influenzae type b in PRP-tetanus toxiid conjugate vaccine", BIOLOGICALS, vol. 26, 1998, pages 33 - 38 *
HYUN SUNG KIM ET AL.: "Optimization of the lowry method of protein precipitation from the H. influenzae type b conjugate vaccine using deoxycholic acid and hydrochloric acid", BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, vol. 11, 2006, pages 215 - 222 *
LEI Q. PAULA ET AL.: "Quantitation of low level unconjugated polysaccharide in tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HCl", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 21, 2000, pages 1087 - 1091 *
Q. P. LEI ET AL.: "Quantification of free polysaccharide in Meningococcal polysaccharide-Diphtheria toxoid conjugate vaccines", DEVELOPMENTS IN BIOLOGICALS, vol. 103, 2000, pages 259 - 264 *
ZHANG, PING ET AL.: "Preparation of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to TT", PROG. IN MICROBIOL IMMUNOL, vol. 35, no. 1, February 2007 (2007-02-01), pages 1 - 4 *
ZHANG, YANLING ET AL., VACCINOLOGY, March 2004 (2004-03-01), pages 940 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102175841A (en) * 2010-12-30 2011-09-07 北京民海生物科技有限公司 Method for measuring content of free polysaccharides in meningococcal polysaccharide combo

Also Published As

Publication number Publication date
CN102175841A (en) 2011-09-07

Similar Documents

Publication Publication Date Title
WO2012088762A1 (en) Method for determining free polysaccharide content in meningococcal polysaccharide conjugate
US20170157235A1 (en) Method for producing and vaccine composition of neisseria meningitidis serogroups a, c, y, and w-135 oligosaccharides conjugated to glycan-free carrier protein
Nyati et al. Role of Campylobacter jejuni infection in the pathogenesis of Guillain‐Barre syndrome: An update
JP2011068676A (en) Method for enhancing immunogenicity for meningococcal vaccination
JP2014193929A (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccines
WO2016155581A1 (en) Isolated and purified acellular pertussis-haemophilus influenza type b-serogroup a and serogroup c meningococcal joint vaccine and preparation method therefor
Jeong et al. Standardization of house dust mite extracts in Korea
WO2017036136A1 (en) A-group and c-group neisseria meningitidis polysaccharide conjugate vaccine activating process
WO2014114125A1 (en) Preparation method of periplaneta americana extract
CN101072586A (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
JP2012140456A (en) Multivalent meningococcal derivatized polysaccharide-protein conjugate and vaccine
US20110070259A1 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
Ma et al. Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice
US10526365B2 (en) Allergoids derived from allergenes
Deo et al. Upregulation of oxidative stress markers in human microvascular endothelial cells by complexes of serum albumin and digestion products of glycated casein
WO2014083171A1 (en) Natural compounds for use in the treatment of beta-2 adrenergic receptor related diseases
US20170333546A1 (en) Method for Producing and Vaccine Composition of Neisseria Meningitidis Serogroups A, C, Y, and W-135 Oligosaccharides Conjugated to Glycan-Free Carrier Protein
Perlowagora et al. The Complement Fixation Test in Yellow Fever Epidemiology: The Use of Globulin Antigen in Immunity Surveys
WO2016009010A1 (en) Composition of allergen extracts having reduced toxicity and method of production thereof
AU2014213504B2 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines
Bogaert et al. Susanne P. Stoof1, 2, Fiona RM van der Klis1, Debbie M. van Rooijen1, Debby
TW200846663A (en) Apparatus and method for isolating iron components from serum
Fox et al. Changing ethnicity in peanut allergy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11853085

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11853085

Country of ref document: EP

Kind code of ref document: A1